The Role of SGLT2 Inhibitors and Weight Loss
Combining Flozins and GLP-1s for maximum renal protection.
Written by Professor Mohammed Mahdi Althaf
# SGLT2 Inhibitors and Weight Loss\n\n## Overview\nSGLT2 inhibitors (like Dapagliflozin) and GLP-1s are the 'dual pillars' of modern nephrology. We explain how they work together.
This article is general information and is not individual medical advice. Treatment decisions are made at a face-to-face consultation.